August 29, 2016 11:48 AM ET

Biotechnology

Company Overview of Aldeyra Therapeutics, Inc.

Executive Profile

Todd C. Brady M.D., Ph.D.

Chief Executive Officer, President, Director and Member of Stock Option Committee, Aldeyra Therapeutics, Inc.
AgeTotal Calculated CompensationThis person is connected to 13 Board Members in 13 different organizations across 14 different industries.

See Board Relationships
44$1,076,598
As of Fiscal Year 2015

Background

Dr. Todd C. Brady, M.D., Ph.D., has been the Chief Executive Officer and President of Aldeyra Therapeutics, Inc. since January 2012. Dr. Brady is a Co-Founder of Phenome Sciences and serves as its Chief Executive Officer. He serves as a Senior Advisor at Solidus Investment Co., Ltd. He served as Principal Financial and Accounting Officer of Aldeyra Therapeutics, Inc. He was an Entrepreneur-In-Residence at Domain Associates, L.L.C since 2013. He joined Domain Associates ...

Corporate Headquarters

131 Hartwell Avenue
Lexington, Massachusetts 02421

United States

Phone: 781-761-4904
Fax: --

Board Members Memberships

Director
Board Observer
Director
Director
Board Observer
2005-Present
Chief Executive Officer, President, Director and Member of Stock Option Committee
2006-Present
Director
2007-Present
Director, Chairman of Nominating & Corporate Governance Committee and Member of Compensation Committee
2007-Present
Director
2014-Present
Independent Director, Member of Audit Committee and Member of Nominating & Corporate Governance Committee
2016-Present
Director

Education

MD 1999
Duke University Medical Center
BA 1993
Dartmouth College
PhD 1998
Duke University
PhD 1998
The Graduate School, Duke University

Other Affiliations

Annual Compensation

Salary$400,000
Total Annual Compensation$400,000

Stocks Options

All Other Compensation$4,564
Exercisable Options$298,568
Unexercisable Options$236,600
Total Number of Options$535,168

Total Compensation

Total Annual Cash Compensation$548,564
Total Short Term Compensation$400,000
Other Long Term Compensation$4,564
Total Calculated Compensation$1,076,598
 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Aldeyra Therapeutics, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.